SCHEMBL5165920

SCHEMBL5165920

COc1cccc2c1c(N(C)C)c(C(=O)N(C)c1ccccc1)c(=O)n2C

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.61
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ PGR P06401 1/20 0.55
▸ SRC P12931 1/20 0.47
▸ MAP3K5 Q99683 1/20 0.41
▸ POLB P06746 4/20 0.40
▸ PABPC1 P11940 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.38
▸ TACR1 P25103 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ DRD2 P14416 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ BRPF1 P55201 1/20 0.36
▸ GPBAR1 Q8TDU6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6994317 0.88 HDAC4 (0.77) HDAC4MEN1KMT2APGRSRC
SCHEMBL5167488 0.87 HDAC4 (0.48) HDAC4MEN1KMT2APGRMAP3K5
SCHEMBL5166909 0.87 HDAC4 (0.61) HDAC4MEN1KMT2APGRSRC
SCHEMBL5165191 0.85 KMT2A (0.58) HDAC4MEN1KMT2APGRSRC
SCHEMBL5163448 0.85 HDAC4 (0.59) HDAC4MEN1KMT2APGRSRC
SCHEMBL5164446 0.84 MEN1 (0.57) HDAC4MEN1KMT2APGRSRC
SCHEMBL5163531 0.81 MEN1 (0.54) HDAC4MEN1KMT2APGRSRC
SCHEMBL7721669 0.81 HDAC4 (0.55) HDAC4MEN1KMT2APGRSRC
SCHEMBL19398184 0.80 HDAC4 (0.79) HDAC4MEN1KMT2APGRSRC
SCHEMBL10670006 0.80 KMT2A (0.74) HDAC4MEN1KMT2APGRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224172-B1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2007-04-04 — — EP disclosed
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 — — EP disclosed
US-6395750-B1 Includes laquinimod, N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxo-quinoline-3-carboxamide and its salts; breat or prostate cancer ACTIVE BIOTECH AB (SE) 2002-05-28 — — US disclosed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 — — WO disclosed
Send feedback